AI assistant
Medtronic plc — Director's Dealing 2018
Jun 11, 2018
29841_dirs_2018-06-11_222d4bb7-3023-48a7-b7e9-1feb78899560.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2018-06-08
Reporting Person: Kuntz Richard (SVP & Chief Medical & Science)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-06-08 | Ordinary Shares | S | 11500 | $87.13 | Disposed | 105923 | Direct |
Footnotes
F1: The price is a weighted average price. These shares were sold in multiple transactions in prices ranging from $87.09 to $87.155, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote in this Form 4.
F2: This balance increased by 316 shares due to exempt transactions such as dividend reinvestment.